Skip to content

Clinical trials

Hemosiderosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemosiderosis Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20042
20051
20072
20121
20131
20151
20161
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
University of Wisconsin, Madison2
ApoPharma1
Assistance Publique - Hôpitaux de Paris1
Centre Hospitalier Sud Francilien1
Gruppo Italiano Malattie EMatologiche dell'Adulto1
HaEmek Medical Center, Israel1
Novartis1
Seoul National University Hospital1
The Geneva Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemosiderosis14
Iron Overload8
Thalassemia4
beta-Thalassemia4
Hemochromatosis2
Anemia1
Anemia, Sickle Cell1
Asthma1
Bronchiolitis1
Down Syndrome1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.